These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 10778970

  • 1. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
    Kornblau SM, Vu HT, Ruvolo P, Estrov Z, O'Brien S, Cortes J, Kantarjian H, Andreeff M, May WS.
    Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
    [Abstract] [Full Text] [Related]

  • 2. The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.
    Kornblau SM, Thall PF, Estrov Z, Walterscheid M, Patel S, Theriault A, Keating MJ, Kantarjian H, Estey E, Andreeff M.
    Clin Cancer Res; 1999 Jul; 5(7):1758-66. PubMed ID: 10430080
    [Abstract] [Full Text] [Related]

  • 3. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
    Schaich M, Illmer T, Seitz G, Mohr B, Schäkel U, Beck JF, Ehninger G.
    Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
    [Abstract] [Full Text] [Related]

  • 4. Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.
    Kornblau SM, Andreeff M, Hu SX, Xu HJ, Patel S, Theriault A, Koller C, Kantarjian H, Estey E, Deisseroth AB, Benedict WF.
    Clin Cancer Res; 1998 Aug; 4(8):1955-63. PubMed ID: 9717825
    [Abstract] [Full Text] [Related]

  • 5. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig WD, Wuchter C.
    Clin Cancer Res; 2004 Jun 01; 10(11):3737-44. PubMed ID: 15173080
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park Ti, Shin DG, Sohn KR, Lee KB.
    Am J Hematol; 2003 Jun 01; 73(2):101-7. PubMed ID: 12749011
    [Abstract] [Full Text] [Related]

  • 7. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
    Schiller AB, Clark WS, Cotsonis G, Lawson D, DeRose PB, Cohen C.
    Cytometry; 2002 Aug 15; 50(4):203-9. PubMed ID: 12210599
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C, Leonid K, Ruppert V, Schrappe M, Büchner T, Schoch C, Haferlach T, Harbott J, Ratei R, Dörken B, Ludwig WD.
    Haematologica; 2000 Jul 15; 85(7):711-21. PubMed ID: 10897123
    [Abstract] [Full Text] [Related]

  • 9. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B, Gao YR, Wang C, Yan SK, Cai Q, Jiang JL, Yang J, Bai HT, Zhao M, Zhao CX.
    Ai Zheng; 2006 Aug 15; 25(8):1007-12. PubMed ID: 16965684
    [Abstract] [Full Text] [Related]

  • 10. The rate of apoptosis and expression of Bcl-2 and Bax in leukocytes of acute myeloblastic leukemia patients.
    Dabrowska M, Pietruczuk M, Kostecka I, Suchowierska M, Kloczko J, Nasilowska B, Bany-Laszewicz U, Marianska B.
    Neoplasma; 2003 Aug 15; 50(5):339-44. PubMed ID: 14628086
    [Abstract] [Full Text] [Related]

  • 11. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb 15; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 12. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
    DiGiuseppe JA, Kastan MB, Weng LJ, Gore SD.
    In Vivo; 1999 Feb 15; 13(1):1-6. PubMed ID: 10218124
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
    Kim JS, Eom JI, Cheong JW, Choi AJ, Lee JK, Yang WI, Min YH.
    Clin Cancer Res; 2007 Feb 01; 13(3):1019-28. PubMed ID: 17289898
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS, Waelchli L, Bründler MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6489-96. PubMed ID: 14695153
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 15; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 16. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F, Núñez-Villar MJ, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2003 Jan 15; 23(1B):565-8. PubMed ID: 12680147
    [Abstract] [Full Text] [Related]

  • 17. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.
    Anticancer Res; 2001 Jan 15; 21(1A):253-9. PubMed ID: 11299743
    [Abstract] [Full Text] [Related]

  • 18. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
    Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D.
    In Vivo; 2007 Jan 15; 21(1):123-32. PubMed ID: 17354625
    [Abstract] [Full Text] [Related]

  • 19. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F, O'Brien S, Cortes J, Verstovsek S, Bueso-Ramos C, Shan J, Pierce S, Garcia-Manero G, Keating M, Kantarjian H.
    Cancer; 2005 Aug 01; 104(3):547-54. PubMed ID: 15973664
    [Abstract] [Full Text] [Related]

  • 20. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
    Köhler T, Würl P, Meye A, Lautenschläger C, Bartel F, Borchert S, Bache M, Schmidt H, Holzhausen HJ, Taubert H.
    Anticancer Res; 2002 Aug 01; 22(3):1553-9. PubMed ID: 12168836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.